Evaluation of the use of systemic antimicrobial agents by professionals for the treatment of periodontal diseases
AUTOR(ES)
Monteiro, Aline Vicentini, Ribeiro, Fernanda Vieira, Casarin, Renato Corrêa Viana, Cirano, Fabiano Ribeiro, Pimentel, Suzana Peres, Casati, Márcio Zaffalon
FONTE
Braz. J. Oral Sci.
DATA DE PUBLICAÇÃO
2013-12
RESUMO
AIM: To investigate the indication of systemic antimicrobial agents used by dental professionals for treatment of patients affected by periodontal diseases. METHODS: Interviews by a questionnaire were held with 225 professionals of different dental specialties and who performed periodontal treatment. RESULTS: Among interviewees, 94% indicated systemic antibiotics as a form of periodontal disease treatment. Their main indication was for periodontal abscesses (80%) followed by aggressive periodontitis (62%) and necrotizing diseases (45%). The most frequently used antibiotics were amoxicillin (81%) and metronidazole (57%). The medications were indicated in association with mechanical therapy by 67% of the professionals. As regards the occasion of indication, 60% indicated systemic antibiotic therapy before and after mechanical periodontal scaling and root planing. Seventy-eight percent of the professionals indicated antibiotics associated with periodontal surgery for access to scaling, and 76% indicated it before and after the surgical procedure. Among the interviewees, 99% took into account systemic involvement for drug administration. CONCLUSIONS: It was concluded that a considerable portion of professionals indicate systemic antibiotic-therapy in an incoherent manner and in situations in which there is no indication for antibiotic use, or with ineffective protocols.
Documentos Relacionados
- Association between periodontal diseases and systemic diseases
- Use of Mutator Strains for Characterization of Novel Antimicrobial Agents
- Use of Fluoroquinolone Antimicrobial Agents by Cardiovascular and Cardiopulmonary Surgeons
- Animal models in the evaluation of antimicrobial agents.
- The use of stem cells for the treatment of autoimmune diseases